Report: U.S. Alzheimer's Disease Medication Markets

U.S. Alzheimer's Disease Medication Markets

Published by

Frost & Sullivan

Published

2007/05

Content info

123 Pages

Product code

FS52433

Price

From US $ 6000

PDF by E-Mail

Approx. 1-2 business days

Hard Copy/CD-ROM

Approx. 3-4 business days

If you need expedited delivery, please call us.

Abstract

The U.S. Alzheimer' s disease medication markets research service provides revenue and patient forecasts, competitive analysis, market trends, product analysis and strategies for growth. The market is segmented by product type into cholinesterase inhibitors, NMDA receptor antagonists and new mechanism drugs. Each of the segments discusses in detail marketed products, revenue forecasts, product pipeline and competitive structure.

Related Report

Alzheimer disease - new drugs, markets and companies Drug Delivery in Central Nervous System Diseases - technologies, markets and companies Neuroprotection - Drugs, Markets and Companies Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential Commercial Insight: Parkinson's Disease - Japan and Europe to drive total market growth